Net Health Agreement with MIMEDX Streamlines Complex Audits of Insurance Benefits | State
PITTSBURGH, October 13, 2021 / PRNewswire / – Net health, a leading provider of cloud-based and analytics software for specialty medical providers, today announced that it has added MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX”) to the list of leading wound care providers who rely on Net Health® the ordering platform in the Wound Care table, CTP connections. Through the agreement, inpatient and outpatient wound care providers can quickly and efficiently submit electronic insurance verification forms and obtain approvals for MIMEDX tissue products.
MIMEDX is an industry leader in the use of amniotic tissue as a platform for regenerative medicine, placental tissue allograft development and distribution with patented and patented processes for multiple health sectors. MIMEDX Advanced Wound Care’s flagship product, EPIFIX®, is covered by 100% of national commercial payers for the treatment of diabetic foot ulcers.
Net Health Wound Care, formerly WoundExpert®, is the Company’s proprietary electronic health record (EHR) platform for wound care management. It is the most widely deployed EHR for wound care in the country, used by more than 20,000 clinicians in hospitals and ambulatory wound clinics.
Using the Connections module to submit assurance verification forms for MIMEDX products brings significant benefits and value to customers of both companies. Busy clinicians can spend less time on administrative tasks and more time on patient care. In addition, the insurance approval time can be significantly reduced.
“The insurance verification process can be tedious, lengthy and prone to errors,” said Jessica duryea, director of national connections and data at Net Health. “Through the use of the login module, Net Health Wound Care users can submit patient information electronically, which minimizes time spent and errors, and ensures faster turnaround times for companies. insurance.
Electronic submission of insurance verification forms for MIMEDX products is included free of charge for Net Health Wound Care customers and will be available nationwide from October. Using the Connections module, clinicians will be able to:
- Submit insurance verification requests for MIMEDX products
- Efficiently provide the required supporting documents
- Avoid paper forms and manual data entry, which means less room for error
- Maintain history and submit verification requests from patient records
“Through this partnership with Net Health, we can further streamline patient access to our EPIFIX® and EPICORD® portfolio for their chronic wounds and allow clinicians to devote more time to patient care,” said Rohit Kashyap, Ph.D., Commercial Director of MIMEDX. “We are committed to increasing patient access to our proprietary PURION® tissue processing technologies, and continue to strengthen our market-leading reimbursement and insurance verification services to provide options that help meet to the needs of our customers. “
For more information on Net Health Wound Care and the Connections module, visit https://www.nethealth.com/contact/.
About net health
Net Health’s mission is to harness data for human health. Net Health solutions are approved in more than 24,000 facilities across the continuum of care. Our EHR software enables caregivers and their organizations to effectively engage with patients, streamline documentation, staff efficiently, ensure appropriate maximum reimbursement, and maintain regulatory compliance. Our unique approach to analytics transparently presents information about clinical and operational workflows to improve care and business performance. Net Health is a holding company of The Carlyle Group, Level Equity and Silversmith Capital Partners. www.nethealth.com.
MIMEDX is an industry leader in the use of amniotic tissue as a platform for regenerative medicine, placental tissue allograft development and distribution with patented and patented processes for multiple health sectors. As a pioneer in placental biologics, we have both a core business, focused on meeting the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline to reduce pain and to improve the function of patients with degenerative musculoskeletal disorders. . We derive our products from human placental tissue and process these tissues using our proprietary methods, including the PURION® process. We use current good tissue practices, current good manufacturing practices and terminal sterilization to produce our allografts. MIMEDX has delivered more than two million allografts, both by direct shipment and by consignment. For more information, please visit www.mimedx.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/net-health-agreement-with-mimedx-streamlines-complex-insurance-benefits-verifications-301398878.html
SOURCE Net Health Systems, Inc.